+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BERLDRG BERLDRG

Beryl Drugs Share Price

₹23.69 +0.48 (2.07%)
48.81% Gain from 52W Low

18 Sep, 2026 4:01 PM (IST)

Beryl Drugs live price: ₹23.69. It opened at ₹24 vs previous close ₹23; intraday high/low: ₹24/₹22. The 50 & 200 DMA stand at ₹23.10/₹22.60.

Beryl Drugs Performance

  • Today's Low
  • ₹22
  • Today's High
  • ₹24
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹28
  • Open Price₹24
  • Previous Close₹23
  • Volume905
  • 50 DMA₹23.10
  • 100 DMA₹22.70
  • 200 DMA₹22.60

Beryl Drugs Chart

Investment Returns

  • Over 1 Month + 0.38%
  • Over 3 Month + 6.04%
  • Over 6 Month + 10.7%
  • Over 1 Year + 3.72%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.2
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 12
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.1
  • EPS
  • 1.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.3
  • RSI
  • 51.14
  • MFI
  • 47.82

Latest Stock News Updates

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper Publication

NEWSPAPER PUBLICATION OF 33RD ANNUAL GENERAL MEETING NOTICE

Beryl Drugs Ltd - 524606 - Reg. 34 (1) Annual Report.

ANNUAL REPORT 2025-2026

Beryl Drugs Ltd - 524606 - 33RD ANNUAL GENERAL MEETING NOTICE TO BE HELD ON 29TH SEPTEMBER, 2026 AT 11 A.M. AT KANCHAN PALACE COMMUNITY HAII, NIPANIA RING ROAD, INDORE

33RD ANNUAL GENERAL MEETING NOTICE

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹23.69
+ 0.48 (2.07%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹23.70
  • 50 Day
  • ₹23.10
  • 100 Day
  • ₹22.70
  • 200 Day
  • ₹22.60

Resistance and Support

23.3 Pivot Speed
  • R3 25.90
  • R2 24.90
  • R1 24.30
  • S1 22.70
  • S2 21.70
  • S3 21.10

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-02 A.G.M.
2026-08-11 Quarterly Results
2026-06-16 Others Inter alia, to consider and approve change in registered office of the company within local limits of the same city.
2026-05-28 Audited Results
2026-04-01 Notice of EGM & Others Inter-alia, to consider 1. Appointment of Mr. Shailendra Pathak as the Whole Time Director. 2. Appointment of Abhay Bhandari & Associates. 3. Authorize Directors of the Com. 4.Other business matters.

Beryl Drugs Shareholding Pattern

72.19%
27.82%
0%

Beryl Drugs FAQs

Beryl Drugs share price is ₹23 As on 21 September, 2026 | 07:23

The Market Cap of Beryl Drugs is ₹12 Cr As on 21 September, 2026 | 07:23

The P/E ratio of Beryl Drugs is 19.2 As on 21 September, 2026 | 07:23

The PB ratio of Beryl Drugs is 1.2 As on 21 September, 2026 | 07:23

The 52 week High & Low of Beryl Drugs is ₹27.6/₹15.9 respectively As on 21 September, 2026 | 07:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23